All Online

13 - 18 of 18 results

Refine

Active filters

person stepping on scale
0.5 CME CREDIT

Addressing “Diabesity”: Weight Loss as a Key Therapeutic Goal in the Management of T2DM (Module 1)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.04 Pharmacology


man taking sample for testing
0.5 CME CREDIT

The Role of GIP and GLP-1 in the Pathophysiology of T2DM and Why it Matters (Module 2)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.42 AANP | 0.42 Pharmacology


doctors at a speech
0.5 CME CREDIT

Updates From the 2021 EASD and ADA Annual Meetings on Dual GIP/GLP-1 RA Therapy: What You Should Know (Module 3)

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.40 Pharmacology


Frankly Speaking CME 270
0.25 CME CREDIT

Boosting Weight Loss with Medications: New Support for GLP-1 RAs - Frankly Speaking EP 270

Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato

0.25 CME

You know GLP-1 RAs are an important class of agents for weight loss, but do you know which drug within this class is right for your patient? This brief podcast walks you through the recent evidence from the STEP 8 randomized clinical trial, comparing the efficacy and adverse reaction profiles for 2 GLP-1 RAs: semaglutide (Wegovy) and liraglutide (Saxenda). This is a must-listen for anyone looking to optimally individualize care for patients with obesity.


doctor giving child a blood pressure reading
0.5 CME CREDIT

Cardiovascular risk factors leading to the leading causes of death in the United States have their origins in the pediatric age group. This session is intended to give primary care providers a high level view of screening and management for cardio-metabolic risk factors in the pediatric age group based on the most up-to-date guidelines.


Close up of someone tying their shoe
1 CME CREDIT

This presentation will provide an overview of the scientific evidence supporting the utility of exercise in maintaining health and decreasing the risk of chronic diseases including diabetes, hypertension, cancer, coronary heart disease, depression. In addition, we will review the evidence showing that exercise can mitigate the risk incurred by diseases like diabetes and hypertension. Then we will discuss a practical approach for discussing exercise with patients/clients and helping patients achieve successful outcomes with lifestyle modification.